Research

• HDSA Research
• Grant Applications
• Research News & Reports
  • Teva Pharmaceutical Industries to Purchase Huntexil from Neurosearch
  • Postcard from CHDI February 2011
  • HD Insights Volume 3
  • Auspex Pharmaceuticals Plans Phase III Clinical Trial for Chorea in HD Patients
  • Research News Archive
    • GABA stell cells
    • proteomic analysis
    • Methylene Blue
    • A New Gene Silencing Technique Enters the Pipeline
    • Hayden Study NMDAR Memantine
    • ACR16
    • MermaiHD ACR-16 (Huntexil) Trial Results
    • MermaiHD Data Adjustment
    • SIRT2 inhibition not promising
    • Ray Truant and Colleagues Publish Promising Findings
    • GM1
    • Melatonin Delays Onset of HD in Mouse Model
    • Track-HD Dec 2012 Announcement
    • New Prion Research Focuses Attention on the UPR in HD
    • CIRM Awards $18 Million to UC-Davis for HD Stem Cell Research
    • PostcardCHDI
    • Omeros
    • ENCODE Study finds "genetic switches"
    • Video Postcard from CHDI 2012 Conference
    • Researchers Restore Neuron Function using iPSCs
    • Lundbeck CHDI Collaboration
    • Video Postcards from Prauge
    • EHDN Nightly News
    • HDL2 News Page
    • Steven Hersch Interview
    • Siena Biotech
    • Prana Planning
    • Mechanism Matters
    • Toxic Protein Form
  • Roche and ISIS form HD Alliance
  • FDA Selects HD for Patient-Focused Drug Development
  • ASO treatment delivered to Alzheimer's patients in Phase I Study
  • Pharmacological Treatment of Chorea in HD Clinical Practice
  • Omeros Phase I OMS824 Trial Results Positive
• Research Webinar Series
• Clinical Trials
• HD Gene Symposium: 20 Years
• Therapies in Pipeline
• Research Conferences
• Scientific Advisory Board
• Research Pipeline
• Stem Cells
• HDBuzz
• HD Glossary
• Links to Other Research
• Past & Future
• HD Insights
• Reports Library